Polynucleotide Capture Materials, and Method of Using Same

• US 20100009351A1
• Filed: 07/11/2008
• Published: 01/14/2010
• Est. Priority Date: 07/11/2008
• Status: Abandoned Application

• Current Assignee: HandyLab Incorporated (Becton Dickinson & Co)
• Original Assignee: HandyLab Incorporated (Becton Dickinson & Co)
• Inventors: Craig, Elizabeth, Handique, Kalyan, Brahmasandra, Sundaresh N.
• Application Number:
  US12/172,208
• Publication Number:
  US 20100009351A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12N 15/1006 by means of a solid support carrier, e.g. particles, polymers

Abstract

Methods for processing polynucleotide-containing biological samples, and materials for capturing polynucleotide molecules such as DNA from such samples. The DNA is captured by polyethyeleneimine (PEI) bound to a surface, such as the surface of magnetic particles. The methods and materials have high efficiency of binding DNA and of release, and thereby permit quantitative determinations.

Claims

1. A method for isolating DNA from a cell-containing sample, the method comprising:

contacting the sample with a lysis solution and a plurality of binding particles coated in polyethyleneimine, so that the DNA is liberated from the cells and becomes reversibly bound to the polyethyleneimine, thereby creating binding particles bound with DNA and a solution containing residual cellular matter;

compacting the binding particles bound with DNA;

removing the solution containing residual cellular matter;

washing the binding particles; and

releasing the DNA from the binding particles.

2. The method of claim 1, wherein the DNA has a size less than 7.5 Mbp.

3. The method of claim 1, wherein the polyethyleneimine is covalently bound to the surface of the plurality of binding particles.

4. The method of claim 1, wherein the polyethyleneimine has a molecular weight in the range 600-800 Da.

5. The method of claim 1, wherein the particles are made of a polymeric material selected from the group consisting of:

polystyrene, latex polymers, polyacrylamide, and polyethylene oxide.

6. The method of claim 5, wherein the polymeric material is modified to provide one or more carboxylic acid groups, wherein the carboxylic acid groups provide an attachment point for the polyethyleneimine.

7. The method of claim 1, wherein the particles are magnetic.

8. The method of claim 7, wherein the particles have an average diameter of between about 0.5 microns and about 3 microns.

9. The method of claim 1, wherein the particles are non-magnetic and have an average diameter of between about 0.5 microns and about 10 microns.

10. The method of claim 1, wherein the particles are present in a density of about 10⁷-10⁹ particles per milliliter.

13. The method of claim 1, wherein the sample is any one of:

vaginal-rectal swab, blood, urine, plasma, CSF, endocervical and urethral swab, pus, M4/UTM/Todd Hewitt broth, buccal swab, nasal swab, sputum, or water.

14. The method of claim 1, wherein the sample is a matrix comprising a genetically-modified crop product.

18. The method of claim 1, wherein the sample comprises cells of a pathogen, and DNA from the cells of the pathogen become bound to the polyethyeleneimine.

19. The method of claim 18, wherein the pathogen is Group B Streptococcus, and contacting the sample with the lysis solution and plurality of binding particles comprises incubating the sample with the solution and particles at 60°

C. for 5-10 minutes.

20. The method of claim 18, wherein the pathogen is Chlamydia, and contacting the sample with the lysis solution and plurality of binding particles comprises incubating the sample with the solution and particles at 37°

C. for 5-10 minutes.

29. The method of claim 1, wherein the method does not comprise centrifugation of the particles.

30. The method of claim 1, wherein the time required for completing the contacting, compacting, removing, washing, and releasing is between 10 and 30 minutes.

32. The method of claim 1, wherein the sample has a volume larger than the concentrated volume of the binding particles having the DNA bound thereto by a factor of at least about 10.

33. The method of claim 1, wherein the sample has a volume from 0.5 microliters to 3 milliliters, and the volume of the compacted particles is 2-3 μ

l.

34. The method of claim 1, wherein the ratio by weight of the DNA captured by the binding particles, to the binding particles prior to contact with the DNA, is 5-20%.

38. The method of claim 1, wherein the binding particles release 90% or more of the DNA bound thereto.

39. The method of claim 1, wherein the sample has a volume of 100 μ

l-1 ml, and the compacted beads occupy an effective volume of less than 2 microliters.

43. The method of claim 1, wherein the particles are magnetic and the compacting comprises collecting the particles by applying an external magnetic field.

11. (canceled)

12. (canceled)

15. (canceled)

16. (canceled)

17. (canceled)

21. (canceled)

22. (canceled)

23. (canceled)

24. (canceled)

25. (canceled)

26. (canceled)

27. (canceled)

28. (canceled)

31. (canceled)

35. (canceled)

36. (canceled)

37. (canceled)

40. The method of claim 40, wherein after removal of the solution containing residual cellular matter, less than 10 microliters of solution is left along with the particles.

41. The method of claim 40, wherein the volume of wash buffer is less than 100 microliters.

42. The method of claim 40, wherein the DNA is released in a volume of less than 20 microliters of release solution.

44. (canceled)

45. (canceled)

46. (canceled)

47. (canceled)

48. (canceled)

49. (canceled)

50. (canceled)

51. A kit, comprising:

a number of sealed tubes, each containing lysis buffer;

a tube containing lyophilized microparticles having polyethyeleneimine bound thereto;

a tube containing liquid wash reagents, sufficient to analyze the number of samples;

a tube containing liquid neutralization reagents, sufficient to analyze the number of samples; and

a tube containing liquid release reagents, sufficient to analyze the number of samples, wherein each component of the kit is stored in an air-tight container.

52. (canceled)

53. (canceled)

54. A kit, comprising:

a first air-tight pouch enclosing a number of tubes, each tube containing lyophilized microparticles having polyethyeleneimine bound thereto;

a second air-tight pouch enclosing a number of reagent holders, each holder comprising;

a tube containing liquid lysis reagents;

a tube containing liquid wash reagents;

a tube containing liquid neutralization reagents; and

a tube containing liquid release reagents.

55. (canceled)

56. (canceled)

57. (canceled)